ArticleScientific reports2026
Genomic and phenotypic characterization of plasmid-mediated extensively drug-resistant Salmonella Typhi from Lahore Pakistan carrying IncY IncQ1 and IncC replicons.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated genomic analysis of Salmonella Typhi from Pakistan: Antimicrobial resistance determinants, pangenome structure, and reverse vaccinology-driven vaccine target discovery.Functional & integrative genomics · 2026Article
- Detection of an ExPEC-likeBiotech (Basel (Switzerland)) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Antimicrobial resistance and emergence of MDR and XDR Salmonella enterica subsp. enterica serovar Typhi is a major threat in Pakistan. Failure of treatment with conventional antibiotics leads to importance of exploring alternative treatment plan. Therefore, this study aimed to check the resistance patterns and delineate the molecular basis of resistance among clinical isolates of S. typhi. 384 clinical isolates of S. Typhi were processed according to standard microbiological techniques. Antimicrobial sensitivity testing was performed by using VITEK-2 compact system. DNA was extracted and Gene specific PCR was done to confirm XDR S. Typhi. Whole Genome Sequencing was performed and Plasmidfinder software was used for plasmids identification. Among 382 S. Typhi, males were predominant which accounted for 61.7% and 43.2% samples were from age group of less than 10 years. Carbapenems and azithromycin showed 100% sensitivity. XDR S. Typhi accounted for 38% of total isolates. Most commonly found plasmids were IncQ1, IncY and IncC. Whole genome assemblies generated using SPAdes v3.15.5 achieved a mean coverage depth of ~ 125 × , revealing the principal plasmid replicons IncQ1, IncY, IncC, and IncA/C2 associated with multidrug resistance in Salmonella Typhi. XDR Salmonella Typhi poses a significant challenge in the treatment of typhoid fever and serious threat for public health. Horizontal transfer of plasmids among Enterobacterales contributes to the emergence and maintenance of XDR S. Typhi.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.